Hyderabad's distinguishing sectors are pharmaceuticals and life sciences alongside IT and a dense concentration of global capability centres. Pharma brings a category of personal data most other industries never touch — clinical trial and pharmacovigilance records — which are governed by their own regimes and now sit inside DPDP's scope as well.
Clinical and pharmacovigilance data comes with existing consent frameworks, retention rules and reporting duties. DPDP does not replace them, and the risk is treating trial consent as though it discharges the Act's separate requirements for the organisation's other processing — recruitment, marketing, patient support programmes.
Patient support and adherence programmes are the softer exposure: they collect health information directly from individuals, often through third-party agencies, and are rarely inside the privacy programme's first scope.
ProtectComply is built by Exuverse, whose team sits in Noida. We work with organisations across India — remotely for most of a programme, in person when discovery or a workshop genuinely needs it.
Trial and pharmacovigilance data is governed by its own consent and retention regimes, and DPDP applies alongside them. Trial consent does not discharge the Act's requirements for the organisation's other processing, such as recruitment, marketing or patient support programmes.
Yes. Where an agency collects health information from individuals on your behalf, you are generally the Data Fiduciary for it, and that data belongs in your inventory and RoPA.
Jupinder Bedi — Jupinder writes on data protection practice at ProtectComply, with a focus on how obligations translate into system behaviour.
Take the free readiness check and find out in 10 minutes.
Start free readiness check →